BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20408735)

  • 1. Selectin inhibitors: a patent review.
    Bedard PW; Kaila N
    Expert Opin Ther Pat; 2010 Jun; 20(6):781-93. PubMed ID: 20408735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X purinergic receptor ligands: recently patented compounds.
    Gunosewoyo H; Kassiou M
    Expert Opin Ther Pat; 2010 May; 20(5):625-46. PubMed ID: 20205618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin receptors and their antagonists: an update on the patent literature.
    Cirino G; Severino B
    Expert Opin Ther Pat; 2010 Jul; 20(7):875-84. PubMed ID: 20450349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent patents in the discovery of small molecule inhibitors of JAK3.
    Wilson LJ
    Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards novel adenosine receptor therapeutics gleaned from the recent patent literature.
    Press NJ; Fozard JR
    Expert Opin Ther Pat; 2010 Aug; 20(8):987-1005. PubMed ID: 20649373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
    Poulsen SA
    Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.
    Magrioti V; Kokotos G
    Expert Opin Ther Pat; 2010 Jan; 20(1):1-18. PubMed ID: 20021282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectins--potential pharmacological targets?
    Kneuer C; Ehrhardt C; Radomski MW; Bakowsky U
    Drug Discov Today; 2006 Nov; 11(21-22):1034-40. PubMed ID: 17055414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectins-an emerging target for drug delivery.
    Ehrhardt C; Kneuer C; Bakowsky U
    Adv Drug Deliv Rev; 2004 Mar; 56(4):527-49. PubMed ID: 14969757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibitors: a patent review.
    Shen HC
    Expert Opin Ther Pat; 2010 Jul; 20(7):941-56. PubMed ID: 20429668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialomucin ligands for selectins: a new family of cell adhesion molecules.
    Lasky LA
    Princess Takamatsu Symp; 1994; 24():81-90. PubMed ID: 8983065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patented PDE10A inhibitors: novel compounds since 2007.
    Kehler J; Kilburn JP
    Expert Opin Ther Pat; 2009 Dec; 19(12):1715-25. PubMed ID: 19939189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New discoveries with mice mutant in endothelial and platelet selectins.
    Hartwell DW; Wagner DD
    Thromb Haemost; 1999 Aug; 82(2):850-7. PubMed ID: 10605793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting selectins for the treatment of inflammatory diseases.
    Impellizzeri D; Cuzzocrea S
    Expert Opin Ther Targets; 2014 Jan; 18(1):55-67. PubMed ID: 24074033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting selectins and selectin ligands in inflammation and cancer.
    Barthel SR; Gavino JD; Descheny L; Dimitroff CJ
    Expert Opin Ther Targets; 2007 Nov; 11(11):1473-91. PubMed ID: 18028011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting P-selectin in acute pancreatitis.
    Hackert T; Büchler MW; Werner J
    Expert Opin Ther Targets; 2010 Sep; 14(9):899-910. PubMed ID: 20608786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectins and mechanisms of signal transduction.
    Crockett-Torabi E
    J Leukoc Biol; 1998 Jan; 63(1):1-14. PubMed ID: 9469467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain.
    Machelska H; Brack A; Mousa SA; Schopohl JK; Rittner HL; Schäfer M; Stein C
    Br J Pharmacol; 2004 Jun; 142(4):772-80. PubMed ID: 15159283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity.
    Uckun FM; Qazi S
    Expert Opin Ther Pat; 2010 Nov; 20(11):1457-70. PubMed ID: 20831363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational selectin-targeted therapy of sickle cell disease.
    Okpala I
    Expert Opin Investig Drugs; 2015 Feb; 24(2):229-38. PubMed ID: 25243412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.